Old Web
English
Sign In
Acemap
>
Paper
>
Evaluation of TPF versus Gefitinib in Residual or Recurrent or Metastatic (R/R/M) Head and Neck Carcinoma
Evaluation of TPF versus Gefitinib in Residual or Recurrent or Metastatic (R/R/M) Head and Neck Carcinoma
2019
Manas Dubey
Faraz Khan
Rajeev Atri
Vivek Kaushal
Anil Kumar Dhull
Rakesh Dhankhar
Keywords:
Cancer Science
Carcinoma
Oncology
Residual
Medicine
Gefitinib
Internal medicine
head and neck carcinoma
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]